Top Markets
#1 Black Phoenix Black Phoenix +173.62%
#2 Islamic Coin Islamic Coin +158.26%
#3 Glidr Glidr +58.56%
#4 Cryptopia Cryptopia +20.42%
#5 DOVU DOVU +18.81%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.03%
#7 Pons Pons +8.77%
#8 MarsCoin MarsCoin +8.69%
#9 stake.link stake.link +8.21%
#10 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +8.18%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Panacos Pharmaceuticals, Inc. Panacos Pharmaceuticals, Inc.

Panacos Pharmaceuticals, Inc.

PANC
Rank in Stocks #42054
Panacos Pharmaceuticals, Inc. functions as an early-stage biotechnology firm... Panacos Pharmaceuticals, Inc. functions as an early-stage biotechnology firm specializing in the research and development of orally administered small-molecule therapeutics. These innovative drugs are crafted to combat human immunodeficiency virus (HIV) and various other viral diseases affecting humans. The company's scientific methodology concentrates on identifying novel targets within the viral life cycle, specifically focusing on processes like virus maturation and fusion. Currently, their product portfolio includes advanced initiatives, such as second- and third-generation programs, centered on inhibiting HIV maturation. Founded in 1999, the company's main operations are situated in Watertown, Massachusetts.
Share Price
$0.0001
Last synced: 2026-08-11
Market Cap
$5.37K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Panacos Pharmaceuticals, Inc. (PANC)

Category

Healthcare
P/S ratio for Panacos Pharmaceuticals, Inc. (PANC)
P/S ratio as of 2026 TTM: 0
According to Panacos Pharmaceuticals, Inc. latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for Panacos Pharmaceuticals, Inc. from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
9.88 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.30 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.98 -
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR